Showing results (1-10 of 651) with videos related to
Sort By:
Pageof 66
Statistics in Medicine|December 18, 2001
Assessment of equivalence on multiple endpointsH Quan, J Bolognese, W YuanGut|September 15, 2000
COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacinG Sigthorsson, R Crane, T Simon, et al.The Nursing Clinics of North America|September 5, 2001
Case studies in osteoporosis management and preventionC J BologneseGastroenterology|September 29, 1999
A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study GroupL Laine, S Harper, T Simon, et al.Arthritis and Rheumatism|February 29, 2000
Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy Multinational Study GroupC Hawkey, L Laine, T Simon, et al.Fertility and Sterility|July 1, 1975
Interruption of pregnancy by prostaglandin 15-methyl F2alphaR J Bolognese, S L CorsonThe Journal of Reproductive Medicine|May 1, 1978
Ibuprofen therapy for dysmenorrheaS L Corson, R J BologneseFertility and Sterility|October 1, 1977
Abortion of early pregnancy on an outpatient basis using Silastic 15(S)-15-methyl prostaglandin F2alpha vaginal devicesS L Corson, R J BologneseThe Journal of Reproductive Medicine|February 1, 1976
Termination of late first-trimester and early second-trimester gestations with intramuscular 15 (S)-15-methyl-prostaglandin F2alphaR J Bolognese, S L CorsonThe Journal of Reproductive Medicine|February 1, 1975
Vaginally administered prostaglandin E2 as a first and second trimester abortifacientS L Corson, R J BolognesePageof 66